Models of hearts, arteries, bones and brains are 3-D printed out of biological materials
As of this month, over 4,000 Americans are on the waiting list to receive a heart transplant. With failing hearts, these patients have no other options; heart tissue, unlike other parts of the body, is unable to heal itself once it is damaged. Fortunately, recent work by a group at Carnegie Mellon could one day lead to a world in which transplants are no longer necessary to repair damaged organs.
“We’ve been able to take MRI images of coronary arteries and 3-D images of embryonic hearts and 3-D bioprint them with unprecedented resolution and quality out of very soft materials like collagens, alginates and fibrins,” said Adam Feinberg, an associate professor of Materials Science and Engineering and Biomedical Engineering at Carnegie Mellon University. Feinberg leads the Regenerative Biomaterials and Therapeutics Group, and the group’s study was published in the October 23 issue of the journal Science Advances. A demonstration of the technology can be viewed online.
“As excellently demonstrated by Professor Feinberg’s work in bioprinting, our CMU researchers continue to develop novel solutions like this for problems that can have a transformational effect on society,” said Jim Garrett, Dean of Carnegie Mellon’s College of Engineering. “We should expect to see 3-D bioprinting continue to grow as an important tool for a large number of medical applications.”
Traditional 3-D printers build hard objects typically made of plastic or metal, and they work by depositing material onto a surface layer-by-layer to create the 3-D object. Printing each layer requires sturdy support from the layers below, so printing with soft materials like gels has been limited.
“3-D printing of various materials has been a common trend in tissue engineering in the last decade, but until now, no one had developed a method for assembling common tissue engineering gels like collagen or fibrin,” said TJ Hinton, a graduate student in biomedical engineering at Carnegie Mellon and lead author of the study.
“The challenge with soft materials — think about something like Jello that we eat — is that they collapse under their own weight when 3-D printed in air,” explained Feinberg. “So we developed a method of printing these soft materials inside a support bath material. Essentially, we print one gel inside of another gel, which allows us to accurately position the soft material as it’s being printed, layer-by-layer.”
One of the major advances of this technique, termed FRESH, or “Freeform Reversible Embedding of Suspended Hydrogels,” is that the support gel can be easily melted away and removed by heating to body temperature, which does not damage the delicate biological molecules or living cells that were bioprinted. As a next step, the group is working towards incorporating real heart cells into these 3-D printed tissue structures, providing a scaffold to help form contractile muscle.
Bioprinting is a growing field, but to date, most 3-D bioprinters have cost over $100,000 and/or require specialized expertise to operate, limiting wider-spread adoption. Feinberg’s group, however, has been able to implement their technique on a range of consumer-level 3-D printers, which cost less than $1,000 by utilizing open-source hardware and software.
The Latest on: 3-D bioprinting
via Google News
The Latest on: 3-D bioprinting
- 3D Bioprinting Market Size, Share, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook 2030 | Says FMI Analyston April 9, 2021 at 2:26 pm
Apr 09, 2021 (MARKITWIRED via COMTEX) -- A recent market study published by Future Market Insights (FMI) on the 3D bioprinting market offers global industry analysis for 2015-2019 & opportunity ...
- 3D Bioprinting Market Size, Share, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook 2030 | Says FMI Analyston April 9, 2021 at 11:45 am
A recent market study published by Future Market Insights (FMI) on the 3D bioprinting market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists ...
- Researchers Devise Rapid 3D Printing Method for Human Organson April 7, 2021 at 6:22 am
Use of hydrogels in novel stereolithography process eyed for fabricating viable tissues for transplants and other biomedical applications.
- 3D Bioprinting Market Share, Demand, Industry Analysis, Growth, Applications, Types and Forecasts Report 2027on April 6, 2021 at 8:36 pm
(MENAFN - GetNews) The study methodologies used to examine the 3D Bioprinting market for the forecast period, 2020 - 2027 further classifies the industry by type, geography, end-use and end-user ...
- 3D Bioprinting Market Share, Demand, Industry Analysis, Growth, Applications, Types and Forecasts Report 2027on April 6, 2021 at 4:28 pm
The MarketWatch News Department was not involved in the creation of this content. Apr 06, 2021 (AB Digital via COMTEX) -- The global 3D Bioprinting Market is expected to reach USD 2,687.8 million by ...
- Moving platform for 3D printing might cut waste, costson April 6, 2021 at 8:56 am
""For standard FDM printers, the materials cost is something like $50 per kilogram, but for bioprinting, it's more like $50 per gram. So if we can save 30% on material that would have gone into ...
- How a moving platform for 3D printing can cut waste and costson April 6, 2021 at 12:25 am
D printing has the potential to revolutionize product design and manufacturing in a vast range of fields—from custom components for consumer products, to 3-D printed dental products and bone and ...
- How a moving platform for 3D printing can cut waste and costson April 5, 2021 at 9:01 pm
but for bioprinting, it's more like $50 per gram. So if we can save 30% on material that would have gone into printing these supports, that is a huge cost saving for 3-D printing for biomedical ...
- 3D Bioprinting Market Analysis by Industry Size, Share, Revenue Growth, Development and Demand Forecast to 2025on April 5, 2021 at 12:36 pm
The Global 3D Bioprinting Market (henceforth referred to as the market studied) was valued at USD 586.13 million in 2019 and is expected to reach USD 1949.94 million by 2025, registering a CAGR of ...
- 3D-Bioprinted Cell Therapy and Disease Modeling Applicationson April 2, 2021 at 4:09 am
Besides contributing to precision medicine directly, they also contribute through 3D bioprinting. In 3D bioprinting, molecular genetics and cell biology are teamed with engineering and robotics to ...
via Bing News